MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Developing a Virtual Brick-Building Group for Veterans with Movement Disorders

    J. Kaplan, C. Kausek, J. Lehosit (Richmond, USA)

    Objective: To improve quality of life for Veterans with movement disorders by creating a virtual group using building bricks Background: Parkinson’s disease (PD) may cause…
  • 2024 International Congress

    A Novel Peer Mentoring Support System for Persons with Parkinson’s Disease

    E. Lubas, TW. Liang, K. Stoveld, SK. Thurman (Philadelphia, USA)

    Objective: Research indicates that peer mentoring approaches can be effective in providing support as well as increasing the well-being of people with various disabilities or…
  • 2024 International Congress

    Experiences of a personalised intervention to support self-management in PwP – PD-Care: Live Well with Parkinson’s

    T. Rookes, K. Kantilal, K. Walters, N. Kime, A. Kassavou, M. Younossi, WN. Tsang, P. Schartau, B. Gardner, N. Davies, A. Schrag (London, United Kingdom)

    Objective: 1) Evaluate acceptability and feasibility of the intervention2) Understand barriers and enablers to engagement and intervention improvement recommendations Background: We co-designed the ‘Live Well…
  • 2024 International Congress

    Benefits of Exercise on Mobility, Balance, and Cognition in Community-Dwelling Older Adults: An On-Land vs. In-Water Comparison Study

    G. Christofoletti, R. de Oliveira, T. Lino, T. Pontin, C. Lorentz, L. Souza, L. Dias (Campo Grande, Brazil)

    Objective: We conducted a three-arm trial (water exercise group × land exercise group × no exercise group) to assess the effects of a 4-month exercise…
  • 2024 International Congress

    Refining Aesthetic Eyebrows: Botulinum Toxin Injection for Hemifacial Spasm.

    S. Maytharakcheep, R. Bhidayasiri, O. Phokaewvarangkul (Bangkok, Thailand)

    Objective: To investigate the efficacy of botulinum toxin injection (BoNTA) in correcting eyebrow asymmetry in patients with hemifacial spasms (HFS). Background: HFS typically affects women…
  • 2024 International Congress

    Orthostatic hypotension in age-related neurodegenerative diseases: a bibliometric study from 2007 to 2023

    Y. Qu, B. Zhang, C. Xing, Y. Yuan (Xi'an, China)

    Objective: This study aims to systematically assess the current landscape and evolving trends of research on orthostatic hypotension in the context of age-related neurodegenerative diseases…
  • 2024 International Congress

    Characterisation of the Pattern of Daily Motor Fluctuations in Patients with Parkinson’s Disease and Early Motor Fluctuations: Findings from the Korean ADOPTION Study

    J. Lee, J. Ferreira, H. Ma, J. Rocha, B. Jeon (Seoul, Republic of Korea)

    Objective: To characterise the pattern of daily motor fluctuations in Korean patients with Parkinson’s disease (PD) and early motor fluctuations. Background: Patients with PD may…
  • 2024 International Congress

    Centralizing brain tissue donation for a large multi-site Parkinson’s disease (PD) study

    L. Heathers, T. Foroud, G. Antonopoulos, K. Mantravadi, B. Lenfert (Indianapolis, USA)

    Objective: Brain tissue analysis is an invaluable resource to better understand PD progression, but there is limited access to this resource and swift postmortem collection…
  • 2024 International Congress

    Treatment Patterns With Long-Term Foslevodopa/Foscarbidopa Use in Parkinson’s Disease

    J. Aldred, T. Henriksen, M. Bouchard, J. Martínez-Castrillo, M. Soileau, D. Standaert, L. Bergmann, R. Gupta, P. Kukreja, M. Shah, S. Isaacson (Spokane, USA)

    Objective: To assess long-term treatment switch patterns and discontinuation rates in patients (pts) with Parkinson’s disease (PD) treated with foslevodopa/foscarbidopa (LDp/CDp) mono- or combination therapy.…
  • 2024 International Congress

    A Post Hoc Efficacy Analysis of Phase 3 Trials of Continuous Subcutaneous Foslevodopa/Foscarbidopa in Patients With Parkinson’s Disease

    M. Soileau, M. Bouchard, I. Malaty, J. Parra, L. Bergmann, R. Gupta, A. Spiegel, E. Freire-Alvarez (Georgetown, USA)

    Objective: To further evaluate the efficacy of foslevodopa/foscarbidopa (LDp/CDp), a soluble formulation of levodopa/carbidopa (LD/CD) prodrugs delivered by 24 hour/day customizable continuous subcutaneous infusion, for…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24187 (not found)
  • #29526 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • “Striatal Hand Signs” and early diagnosis of Parkinson's Disease: The “Monkey-Wrench Sign”.
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley